Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00118014 · ClinicalTrials.gov registry record · Phase 4
Sertraline and Habit Reversal in the Treatment of Patients With Trichotillomania
A Phase 4 study of Impulse Control Disorders, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 75
- Enrollment target
- 1
- Study location
NCT00118014: Completed Phase 4 study of Impulse Control Disorders, sponsored by Massachusetts General Hospital.
NCT00118014 is a Phase 4 study of Impulse Control Disorders that has completed, run by Massachusetts General Hospital. The registered enrollment target is 75 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00118014, a Phase 4 study of Impulse Control Disorders, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess the extent of symptom remission in patients with trichotillomania following treatment with sertraline and/or behavior therapy.
Conditions Studied
Interventions
- DRUG Sertraline
- BEHAVIORAL Habit Reversal Training
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - OCD Clinic - Charlestown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2000-01 |
| Est. Completion | 2004-08 |
| Phase | Phase 4 |
What the finished NCT00118014 record still lists
NCT00118014 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Impulse Control Disorders appearing as the primary indexed condition, and to 2 interventions - of which Sertraline is the first listed.
NCT00118014 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00118014 about?
NCT00118014 is a clinical study titled "Sertraline and Habit Reversal in the Treatment of Patients With Trichotillomania". The purpose of this study is to assess the extent of symptom remission in patients with trichotillomania following treatment with sertraline and/or behavior therapy.
What is the current status of trial NCT00118014?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 75 participants. The study started on 2000-01. Estimated completion is 2004-08.
What conditions does trial NCT00118014 study?
This clinical trial studies the following conditions: Impulse Control Disorders.
What interventions are being tested in trial NCT00118014?
The interventions under investigation include: Sertraline (DRUG), Habit Reversal Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT00118014?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00118014 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Impulse Control Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00118014's enrollment target sits among peer trials
75 1002nd of 2000 higher than 974 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia